0.730
-0.20 (-21.76%)
| Penutupan Terdahulu | 0.933 |
| Buka | 0.780 |
| Jumlah Dagangan | 1,118,599 |
| Purata Dagangan (3B) | 602,701 |
| Modal Pasaran | 16,334,793 |
| Harga / Pendapatan (P/E Ke hadapan) | 0.520 |
| Harga / Jualan (P/S) | 3.16 |
| Harga / Buku (P/B) | 0.240 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 13 May 2026 |
| EPS Cair (TTM) | -5.76 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 1.47% |
| Nisbah Semasa (MRQ) | 0.370 |
| Aliran Tunai Operasi (OCF TTM) | -23.55 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 15.85 M |
| Pulangan Atas Aset (ROA TTM) | -25.32% |
| Pulangan Atas Ekuiti (ROE TTM) | -60.53% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | Citius Pharmaceuticals, Inc. | Bercampur | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | 3.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 2.0 |
| Purata | 1.50 |
|
Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 4.41% |
| % Dimiliki oleh Institusi | 5.69% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Heights Capital Management, Inc | 31 Dec 2025 | 799,934 |
| Asset Advisory Group, Inc. | 31 Mar 2026 | 59,011 |
| Arkadios Wealth Advisors | 31 Dec 2025 | 20,000 |
| Julat 52 Minggu | ||
| Median | 6.00 (721.92%) | |
| Jumlah | 1 Beli | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| D. Boral Capital | 11 Mar 2026 | 6.00 (721.92%) | Beli | 0.910 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |